Fang Wang

Chen Shi Research Team Co-PI

PI介绍

Shenzhen Institute of Translational Medicine, Chen Shi Research Team PI. Graduated with a Ph.D. from the University of Macau in 2021, specializing in Biomedical Sciences. Engaged primarily in research related to pathogenic microorganisms, focusing on investigating the pathogenic mechanisms and microbial physiological properties during infection processes of pathogenic microorganisms (bacteria, fungi). Key research contributions include publications as first or corresponding author in journals such as Nature Microbiology (cover feature), Clinical Microbiology Reviews (cover feature), PLOS Genetics, and Virulence. Principal investigator of 1 National Natural Science Foundation project, 1 sub-project of a Ministry of Science and Technology key special task, and 1 Shenzhen talent project.


教育背景

September 2008 - July 2012: Bachelor's degree in Pharmaceutical Engineering, College of Life Sciences, Inner Mongolia Agricultural University.

September 2012 - June 2015: Master's degree in Microbiology, Taide Institute of Biotechnology, Nankai University.

January 2016 - March 2021: Ph.D. in Biomedical Sciences, Faculty of Health Sciences, University of Macau.


工作经历

Since September 2021, PI of Chen Shi Research Team at the Translational Medicine Research Institute, Shenzhen Second People's Hospital.

研究方向和兴趣

Exploring Pathogenic Mechanisms of Fungal and Bacterial Pathogens Using Multi-omics Approaches

Applying genomics, comparative genomics, and transcriptomics, combined with bioinformatics analysis and molecular biology experiments, to investigate the pathogenic mechanisms and regulatory mechanisms of common clinical pathogenic fungi such as Aspergillus, Candida, and Talaromyces. Concurrently, co-infection events of pathogenic bacteria and fungi are prevalent among clinical patients. Utilizing multi-omics approaches to understand the mutual interactions between pathogenic bacteria and fungi, as well as their interactions with the infected host, can provide theoretical foundations and potential drug targets for clinical diagnosis and treatment.

Transcriptional Regulation Studies in Microorganisms

Transcription, as a crucial step in the central dogma of genetics, represents the first step in manifesting genetic information into various biological features. Whether in prokaryotes or eukaryotes, the cellular gene transcription process is finely regulated to ensure precise adaptation to various environmental conditions. Transcription factors, proteins capable of recognizing and binding specific target DNA sequences, play a pivotal role in transcriptional regulation. Using existing research techniques, including ChIP-Seq, RNA-seq, and DNA-pull down, in combination with large-scale screenings of mutation libraries in response to environmental stimuli and comparative transcriptional responses, studies are conducted on various microbial physiological processes, including bacteria and fungi. Additionally, genomic comparisons of new environmental and clinically isolated strains explore their physiological characteristics, dynamics, and real-time monitoring of response reactions during pathogen invasion processes, aiming to uncover evolutionary changes in clinical strains from multiple aspects such as genomics and epigenetics.


科研项目

[1]. National Natural Science Foundation of China project "Study on the Transcriptional Regulation Mechanisms of Aspergillus nidulansSpore Germination Before and After Breaking Dormancy" (Project Approval Number: 32200024), with a funding amount of 300,000 RMB, Principal Investigator, (2023.01-2025.12).

[2]. National Key Research and Development Program of China "Design and Construction of Synthetic Microbial Systems for Water Environment Pollution Remediation" (Project Approval Number: 2022YFA0912500), Subproject Leader, 341,000 RMB (2022.11-2027.10).

[3]. Shenzhen Excellent Technology Innovation Talent (Doctoral Startup Project) "Molecular Mechanisms of Large Chromosomal Deletions in Aspergillus fumigatusAffecting Pathogenicity" (Project Approval Number: RCBS20221008093108030), with a funding amount of 300,000 RMB, Principal Investigator, (2023.04-2025.04).


代表性成果

1.      Fang Wang, Pooja Sethiya, Xiaohui Hu, Shuhui Guo, Yingying Chen, Ang Li, Kaeling Tan, Koon Ho Wong*. Transcription in fungal conidia before dormancy produces phenotypically variable conidia that maximize survival in different environments. Nature Microbiology. 2021 Aug;6(8):1066-1081IF=28.3(独立第一作者,封面文章,F1000推荐,Nature Microbiology杂志亮点评论)

2.      Fang Wang, Runhua Han, Shi Chen*. An Overlooked and Underrated Endemic Mycosis—Talaromycosis and the Pathogenic Fungus Talaromyces marneffei. Clinical Microbiology Reviews. 2023 Mar 23;36(1):e0005122.IF=36.8)(独立第一作者,封面文章,2023年度高被引)

3.      Ana Cristina Colabardini#, Fang Wang#*, Zhengqiang Miao#, Lakhansing Pardeshi, Clara Valero, Patrícia Alves de Castro, Daniel Yuri Akiyama, Kaeling Tan, Luisa Czamanski Nora, Rafael Silva-Rocha, Marina Marcet-Houben, Toni Gabaldón, Taicia Fill, Koon Ho Wong*, and Gustavo H. Goldman*. Chromatin profiling reveals heterogeneity in clinical isolates of the human pathogen Aspergillus fumigatus. PLoS Genetics. 18(1):e1010001. 2022.IF=4.5(共同第一作者(第2),共同通讯作者

4.      Fang Wang#, Ting Yao#, Wen Yang#, Pan Wu, Yutao Liu, Bin Yang*. Protocol to detect nucleotide-protein interaction in vitro using a non-radioactive competitive electrophoretic mobility shift assay. STAR Protocols. 3(4):101730. 2022.(共同第一作者(第1))

5.      Fang Wang#, Hongmin Sun#, Chenbo Kang, Jun Yan, Jingnan Chen, Xuequan Feng*, and Bin Yang*. Genomic island-encoded regulatory proteins in enterohemorrhagic Escherichia coli O157:H7. Virulence. 2024 (Accepted).IF=5.2(共同第一作者(第1))

6.      Yuan Nong#, Fang Wang#*, Shi Chen*. Morphology, development, and pigment production of Talaromyces marneffei are diversely modulated under physiologically relevant growth conditions. Current Microbiology. 2024 (Accepted).IF=2.6)(共同第一作者(第2),共同通讯作者